Apollomicsinc
2 known investors
Apollomics is a biotechnology company focused on discovering and developing oncology therapies designed to combine with other treatments, using approaches that engage the immune system and target specific molecular pathways to inhibit cancer. It operates as a publicly traded (Nasdaq-listed) drug developer with clinical programs including vebreltinib (APL-101).
BiotechHealthtech
Investors Β· 2
Frequently asked questions
- What does Apollomicsinc do?
- Apollomics is a biotechnology company focused on discovering and developing oncology therapies designed to combine with other treatments, using approaches that engage the immune system and target specific molecular pathways to inhibit cancer. It operates as a publicly traded (Nasdaq-listed) drug developer with clinical programs including vebreltinib (APL-101).
- Who are Apollomicsinc's investors?
- Apollomicsinc's investors include Pan-Lin Capital, Qiming Venture Partners.